December 5, 2014

The FDA issued a draft guidance that would provide generic companies a pathway to obtain samples of medicines requiring a Risk Evaluation and Mitigation Strategy (REMS) protocol for product testing.

December 4, 2014

Alliance Boots on Thursday announced that it has completed the acquisition of a 12% stake in Nanjing Pharmaceutical in China. As a result of the investment, Alliance Boots becomes the second largest shareholder of the company with the right to nominate board members and a member of the senior management.

December 4, 2014

Rite Aid's positive pharmacy results helped fuel a pre-market surge of 2.4% to $5.59 in premarket trading.

December 3, 2014

The Food and Drug Administration published a final rule that sets standards for how information about using medicines during pregnancy and breastfeeding is presented in the labeling of prescription drugs and biological products.

 

December 3, 2014

Walgreens posted November sales of $6.4 billion, an increase of 4.9%.

 

December 2, 2014

Perrigo on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for diclofenac sodium topical solution 1.5% w/w.

December 1, 2014

The Food and Drug Administration recently issued draft guidance on key product tracing provisions of the Drug Supply Chain Security Act, which is expected to be implemented by the industry on Jan. 1, 2015. 

November 20, 2014

The Generic Pharmaceutical Association on Thursday emphasized the savings generic medicines bring to the table in light of rising brand prices. 

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 20, 2014

The Consumer Healthcare Products Association board of directors on Wednesday announced changes to CHPA’s voluntary guidelines addressing dosing of liquid pediatric over-the-counter medicines.

November 19, 2014

The Food and Drug Administration opened a public docket and requested comments on proposed criteria for “first generic” abbreviated new drug application submissions.

 

November 18, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at the impact of the Hatch-Waxman act and Q&A's with industry leaders, in this multi-page report.

November 17, 2014

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

November 17, 2014

DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act. 

November 17, 2014

Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.

November 17, 2014

Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.

November 17, 2014

In this issue, we explore the profile of health-seeking drug store shoppers, their pharmacy purchase behavior and the best times to reach this valuable audience with promotional messages.

November 17, 2014

People who received automated reminders were more likely to refill their blood-pressure and cholesterol medications, according to a study published in the American Journal of Managed Care.

November 17, 2014

Last year, Drug Store News covered extensively the results from Thrifty White's successful medication synchronization program. DSN recently checked in with Tim Weippert, Thrifty White EVP pharmacy, to get an update.

 
November 14, 2014

The Council for Responsible Nutrition has launched a tool that compiles Food and Drug Administration warning letters sent to dietary supplement companies into a searchable database.

November 14, 2014

Jan Reed, Walgreens corporate VP and general counsel currently is working on the completion of the second step of the Walgreens/Alliance Boots merger, which will fully combine the two companies. Reed brings experience across a number of industries, including service, health care and manufacturing, to her role at Walgreens. 

November 14, 2014

Being a mentor and paying it forward is one of the more critical roles of a leader, noted Jill Turner-Mitchael, Sam’s Club SVP health-and-wellness, who hails from Texas and has piloted Sam’s Club’s journey toward becoming a healthcare destination center. 

November 14, 2014

For Jocelyn Wong, SVP, chief marketing officer of Family Dollar, challenging the status quo is what she strives toward each day.

November 14, 2014

CVS Health’s Judy Sansone is widely regarded as a straight-shooting, savvy merchant with experience at various ends of the business. Today she serves as SVP, merchandising and personalization for CVS Health.